Aegon Ltd. Form 6-K Summary: Six Months Ended June 30, 2026
Business Context and Reporting Period
This filing covers the interim financial information for Aegon Ltd. for the six-month period ended June 30, 2026. The company is actively executing a strategic transformation to become a leading US life insurance and retirement group. Key strategic milestones include the selection of New York City as the future head office, the announcement of the sale of Aegon UK to Standard Life for GBP 2.0 billion, and the acceleration of the redomiciliation process to the US, with an Extraordinary General Meeting targeted for October 8, 2026.
Key Financial Metrics
| Metric | 1H 2026 | 1H 2025 (Restated) | Change |
|---|---|---|---|
| Net Result | EUR 608 million | EUR 606 million | Stable |
| Operating Result | EUR 804 million | EUR 741 million | +9% |
| Operating Capital Generation (OCG) | EUR 416 million | Not explicitly stated | +27% vs prior period |
| Free Cash Flow | EUR 392 million | EUR 442 million | -11% |
| Shareholders' Equity | EUR 7,328 million | EUR 7,432 million | -1% |
| Valuation Equity | EUR 13,991 million | EUR 13,709 million | +2% |
| Gross Financial Leverage | EUR 4,967 million | EUR 4,850 million | +2% |
| Group Solvency Ratio | 169% | 184% | -15 percentage points |
Material Changes vs. Prior Period
- Operating Performance: The operating result increased by 9% to EUR 804 million, driven by growth across all units, particularly in the Americas and Asset Management. The Americas operating result rose 3% (10% in local currency), while International results grew 24%.
- Discontinued Operations: Aegon UK is now classified as discontinued operations following the agreement to sell the business to Standard Life. This reclassification impacts comparative figures.
- Assumption Updates: The company conducted an annual assumptions review, resulting in EUR 294 million in "Other charges" primarily due to policyholder behavior variances (higher persistency in older Universal Life policies) and updated mortality assumptions.
- Capital Position: The Group solvency ratio decreased to 169% from 184%. This decline was driven by the loss of capital eligibility for Perpetual Capital Subordinated Bonds, the debt tender offer, and planned capital distributions (dividends and buybacks), partially offset by operating capital generation.
Guidance, Outlook, and Management Commentary
- Revised Financial Ambitions: Following the Aegon UK sale, the Group operating result run-rate is expected to grow by ~5% annually from a pro forma 2025 run-rate of EUR 1.3–1.5 billion. Free cash flow run-rate is expected to grow ~5% annually from EUR 0.68 billion.
- Dividends and Buybacks: Aegon declared an interim dividend of EUR 0.21 per share (up 11% vs. prior year). The company also increased its share buyback program by EUR 150 million, bringing the total for the second half of 2026 to EUR 350 million.
- Strategic Focus: Management highlighted strong commercial growth in Transamerica, with Individual Life sales up 54% and World Financial Group agents exceeding 100,000. The company is on track to meet or exceed its 2026 financial ambitions.
- Risks: Key risks include the successful completion of the redomiciliation and Aegon UK sale, regulatory approvals, market volatility affecting investment returns, and the impact of changing interest rates and policyholder behavior.
Investor Verification Checklist
- Redomiciliation Timeline: Verify the progress of the US redomiciliation process and the scheduling of the October 8, 2026, Extraordinary General Meeting.
- Aegon UK Sale Closing: Monitor the closing of the Aegon UK sale to Standard Life, expected by the end of 2026, and the realization of the GBP 2.0 billion consideration.
- Actuarial Assumptions: Review the impact of the annual assumption review on future profitability, specifically regarding policyholder behavior and mortality updates in the US.
- Capital Management: Track the execution of the EUR 350 million share buyback program and the resulting impact on the Group solvency ratio and Cash Capital at Holding.
- US GAAP Transition: Confirm the timeline for the first release of full-year results under US GAAP, currently targeted for 2027.